Jean-Sébastien Hulot
Jean-Sébastien Hulot
Université Paris Cité
Verified email at
Cited by
Cited by
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), e28-e292, 2014
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology
Task Force Members, G Montalescot, U Sechtem, S Achenbach, ...
European heart journal 34 (38), 2949-3003, 2013
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
JP Collet, JS Hulot, A Pena, E Villard, JB Esteve, J Silvain, L Payot, ...
The Lancet 373 (9660), 309-317, 2009
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
JS Hulot, A Bura, E Villard, M Azizi, V Remones, C Goyenvalle, M Aiach, ...
Blood 108 (7), 2244-2247, 2006
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
SA Scott, K Sangkuhl, CM Stein, JS Hulot, JL Mega, DM Roden, TE Klein, ...
Clinical Pharmacology & Therapeutics 94 (3), 317-323, 2013
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial
P Lechat, JS Hulot, S Escolano, A Mallet, A Leizorovicz, ...
Circulation 103 (10), 1428-1433, 2001
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy
SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ...
Clinical Pharmacology & Therapeutics 90 (2), 328-332, 2011
Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy
JS Hulot, X Jouven, JP Empana, R Frank, G Fontaine
Circulation 110 (14), 1879-1884, 2004
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19* 2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta …
JS Hulot, JP Collet, J Silvain, A Pena, A Bellemain-Appaix, O Barthélémy, ...
Journal of the American College of Cardiology 56 (2), 134-143, 2010
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial
KT Ong, J Perdu, J De Backer, E Bozec, P Collignon, J Emmerich, ...
The Lancet 376 (9751), 1476-1484, 2010
Feasibility and safety of ultrasound-aided thoracentesis in mechanically ventilated patients
D Lichtenstein, JS Hulot, A Rabiller, I Tostivint, G Mezičre
Intensive care medicine 25, 955-958, 1999
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
S Vieira-Silva, G Falony, E Belda, T Nielsen, J Aron-Wisnewsky, ...
Nature 581 (7808), 310-315, 2020
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
N Costedoat‐Chalumeau, Z Amoura, JS Hulot, HA Hammoud, G Aymard, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2006
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E uropean A …
J Čelutkienė, R Pudil, T López‐Fernández, J Grapsa, P Nihoyannopoulos, ...
European journal of heart failure 22 (9), 1504-1524, 2020
Association between ABCC2 Gene Haplotypes and Tenofovir-Induced Proximal Tubulopathy
H Izzedine, JS Hulot, E Villard, C Goyenvalle, S Dominguez, J Ghosn, ...
The Journal of infectious diseases 194 (11), 1481-1491, 2006
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies
H Izzedine, JS Hulot, V Launay-Vacher, P Marcellini, SJ Hadziyannis, ...
Kidney International 66 (3), 1153-1158, 2004
Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis
G Cayla, JS Hulot, SA O’Connor, A Pathak, SA Scott, Y Gruel, J Silvain, ...
Jama 306 (16), 1765-1774, 2011
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
I Abi Nasr, A Bouzamondo, JS Hulot, O Dubourg, JY Le Heuzey, P Lechat
European heart journal 28 (4), 457-462, 2007
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials
JC Corvol, A Bouzamondo, M Sirol, JS Hulot, P Sanchez, P Lechat
Archives of internal medicine 163 (6), 669-676, 2003
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association …
R Pudil, C Mueller, J Čelutkienė, PA Henriksen, D Lenihan, S Dent, ...
European journal of heart failure 22 (11), 1966-1983, 2020
The system can't perform the operation now. Try again later.
Articles 1–20